Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysisTakahide Nakazawa, Wasaburo Koizumi, Hisashi Hidaka et al.|BMC Gastroenterology|2014Cited by 132
Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenibTakahide Nakazawa, Wasaburo Koizumi, Hisashi Hidaka et al.|European Journal of Gastroenterology & Hepatology|2013Cited by 81
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenibManabu Morimoto, Katsuaki Tanaka, Kazushi Numata et al.|Hepatology Research|2011Cited by 77
Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trialHisashi Hidaka, Wasaburo Koizumi, Masaaki Watanabe et al.|Journal of Gastroenterology|2011Cited by 55
Repeat Radiofrequency Ablation Provides Survival Benefit in Patients With Intrahepatic Distant Recurrence of Hepatocellular CarcinomaYusuke Okuwaki, Katsunori Saigenji, Takahide Nakazawa et al.|The American Journal of Gastroenterology|2009Cited by 50